Patent · US Active

SEMA4D antibody, preparation method therefor and use thereof

US12018078B2 · kind B2 · utility

0Cited by

1References

9Claims

0Family size

Assignee

JIANGSU HUAIYU PHARMACEUTICAL CO., LTD. · CN

Inventors

Yingying HU · Ningbo City, CN
Xiaodan CAO · Shanghai, CN
Zihan Jin · Shanghai, CN
Lina Wang · Beijing, CN
Yuandong WANG · Shanghai, CN
Xiaohui SHAO · Shanghai, CN
Shaoping HU · Shanghai, CN
Mingming PAN · Shanghai, CN
Yan Liu · Tangshan City, CN
Wei Shao · Frederick, US
Yanyan Li · Beijing, CN
Xiaoxuan Lan · Shanghai, CN
Ying Gu · Fujian, CN
Siran Zhu · Shanghai, CN
Lile LIU · Shanghai, CN
Qing DUAN · Shanghai, CN

Key dates

Filing date	Jul 15, 2019
Grant date	Jun 25, 2024
Priority date	—
Expiry date	Feb 14, 2041

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/4704
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are a murine or fully human monoclonal antibody targeting SEMA4D and a preparation method therefor, wherein the antibody binds to the SEMA4D antigen and has activities such as combating tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.